Volume 15, Number 7 (Nov/Dec 2024)
In patients with chronic lymphocytic leukemia/small lymphocytic lymphoma, obinutuzumab carries a significant risk of infusion-related reactions (IRRs). An article in this issue evaluated risk factors for the development of IRRs for a risk-adapted administration strategy. Explore the role of the advanced practitioner in the diagnosis, treatment, and symptom management of pancreatic cancer. Medullary renal cell carcinomas are exceedingly rare and rapidly fatal. Read a case study highlighting the characteristics, presentation, rarity, and aggressiveness of medullary renal cell carcinoma.
In the online first section, an article by Stewart and colleagues documents APs’ experiences discussing molecular profiling results with patients. Read about how revising the laxative options in an EHR led to more evidence-based management of opioid-induced constipation. Learn about the successful integration of a clinical pharmacist into a breast cancer clinic and the common supportive care interventions they made to improve symptom control. Often, there is not adequate screening for depression in patients with cancer. This issue’s online first research article looked at increasing screening rates so providers could make referrals to mental health services and help patients adhere to their treatment. Follicular lymphoma (FL) is the second-most common lymphoma in the US, and relapsed/refractory FL remains incurable. An article in this issue compares the safety profiles of approved agents and assessed how to manage adverse events.
